Meet Freya
March 2025
The National Health Surveillance Agency (ANVISA) is once again publishing medical device price data after a temporary pause. This break allowed for process improvements and a data review.
The pause was needed because ANVISA updated its Internal Regulations, moving this responsibility to the Executive Secretariat of the Drug Market Regulation Chamber (SCMED). The agency used this time to refine the system, ensuring more accurate and reliable information.
Price monitoring helps the healthcare industry track costs and make informed decisions. The updated public dashboard now provides essential data for market and regulatory analysis.
Users can access pricing information for key medical devices, including coronary artery stents, implantable pacemakers, defibrillators, and heart valve prostheses.
Region: Latin America
Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.
Speak to an Expert
